Enoxaparin Becat Laboratorios Farmacéuticos Rovi

Enoxaparin Sodium is an anticoagulant medication used to prevent and treat blood clots. It is commonly administered via subcutaneous or intravenous routes, including during haemodialysis.

Enoxaparin Sodium is primarily used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used during haemodialysis to prevent blood clots in the dialysis equipment. This medication works by thinning the blood, making it harder for clots to form. It is often prescribed for patients who are at risk of blood clots due to surgery, prolonged immobility, or certain medical conditions.

Common effects of Enoxaparin Sodium may include bruising, bleeding, and pain at the injection site. Some users may experience nausea, headache, or dizziness. Severe side effects, such as unusual bleeding or signs of an allergic reaction, should be reported to a healthcare provider immediately.

Enoxaparin Sodium should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Enoxaparin Sodium may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be limited as it can increase the risk of bleeding. Patients should also be cautious when using medications that affect blood clotting.